Nanoform Finland Oyj (STO:NANOFS)

Market Cap	810.03M -11.5%
Revenue (ttm)	59.47M +37.7%
Net Income	-175.20M
EPS	-2.08
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,962
Average Volume	50,290
Open	9.42
Previous Close	9.65
Day's Range	9.25 - 9.71
52-Week Range	4.15 - 15.22
Beta	0.56
RSI	61.79
Earnings Date	May 19, 2026

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and dosage forms of Nanoparticles. It also offers STARMAP, an AI platform predic...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 171
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: NANOFS

Financial Performance

In 2025, Nanoform Finland Oyj's revenue was 5.02 million, an increase of 37.10% compared to the previous year's 3.66 million. Losses were -17.90 million, -23.60% less than in 2024.

Financial numbers in EUR